The Pharmacare News Bulletins, which are mailed to pharmacies and prescribers, are listed below. They are an important source of information as they provide timely information on recent changes to the Pharmacare Programs.
Please continue to refer to the Pharmacare News Bulletins to stay current with Formulary and Pharmacare Program updates.
March Bulletin Vol 24-06 (PDF)
New Exception Status Benefits: Skyrizi (risankizumab), Xydalba (dalbavancin hydrochloride), Criteria Updates, Temodal and generic brands (temozolomide), Exjade and generic brands (deferasirox), Jadenu and generic brands (deferasirox); Change in Benefit Status: Olanzapine; New Benefits
March Bulletin Vol 24-05 (PDF)
Paxlovid Availability in Nova Scotia
February Bulletin Vol 24-04 (PDF)
New Exception Status Benefits: Kerendia (finerenone), Saphnelo (anifrolumab), Zeposia (ozanimod); Criteria Update: Brukinsa (zanubrutinib); New Benefits; Temporary Benefit – US-Labelled Glucagon Injection; Pharmacare News Bulletins Online; Updating Pharmacy Licence In CANImmunize; Ozempic Billing Reminder
February Bulletin Vol 24-03 (PDF)
Ozempic and Rybelsus Update
January Bulletin Vol 24-02 (PDF)
January Bulletin Vol 24-01 (PDF)
Cystic Fibrosis Therapies Update
March Bulletin Vol 24-06 (PDF)
New Exception Status Benefits: Skyrizi (risankizumab), Xydalba (dalbavancin hydrochloride); Criteria Updates: Temodal and generic brands (temozolomide), Exjade and generic brands (deferasirox), Jadenu and generic brands (deferasirox); Change in Benefit Status: Olanzapine; New Benefits
March Bulletin Vol 24-05 (PDF)
Paxlovid Availability in Nova Scotia
February Bulletin Vol 24-04 (PDF)
New Exception Status Benefits: Kerendia (finerenone), Saphnelo (anifrolumab), Zeposia (ozanimod); Criteria Update: Brukinsa (zanubrutinib); New Benefits: Temporary Benefit – US-Labelled Glucagon Injection; Pharmacare News Bulletins Online
February Bulletin Vol 24-03 (PDF)
Criteria Update: Ozempic (semaglutide), New Exception Status Benefit, Rybelsus (semaglutide)
January Bulletin Vol 24-02 (PDF)
January Bulletin Vol 24-01 (PDF)
Cystic Fibrosis Therapies Update
Complete Volume Twenty Three 2023 (PDF)
Complete Volume Twenty Two 2022 (PDF)
Complete Volume Twenty One 2021 (PDF)
Complete Volume Twenty 2020 (PDF)
Complete Volume Nineteen 2019 (PDF)
Complete Volume Eighteen 2018 (PDF)
Complete Volume Seventeen 2017 (PDF)
Complete Volume Twenty Three 2023 (PDF)
Complete Volume Twenty Two 2022 (PDF)
Complete Volume Twenty One 2021 (PDF)
Complete Volume Twenty 2020 (PDF)
Complete Volume Nineteen 2019 (PDF)
Complete Volume Eighteen 2018 (PDF)
Complete Volume Seventeen 2017 (PDF)